High-Chondrocyte-Viability Osteochondral Allograft Transplantation in the Knee for Revision of Failed Cartilage Repair Procedures

Revision osteochondral allograft transplantation (OCAT) has historically yielded inferior outcomes compared with primary procedures. This study evaluates outcomes following revision OCAT using high-chondrocyte-viability (HCV) OCAs for functional graft survival. A prospective registry was analyzed for HCV OCAT outcomes. Patients were grouped into primary (<i>n</i> = 182) or revision (<i>n</i> = 70) OCAT cohorts. Demographic, surgical, and follow-up data were collected. Revision cases were further subclassified based on prior cartilage procedures (marrow stimulation, osteochondral, or cell-matrix-based). Functional graft survival and validated patient-reported outcomes were assessed at a mean follow-up of 43 months. At final follow-up (FFU), functional graft survival was 79.1% for primary and 71.4% for revision OCAT. Overall survival at > 2-year follow-up was 84% (primary) and 80% (revision). Patients with failed revision OCAT reported significantly lower Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function scores at 1-year (mean: 40.8, <i>p</i> = 0.026). Bipolar tibiofemoral revisions conferred increased failure rates (odds ratio: 3.86, <i>p</i> = 0.033). Cell-matrix-based revision cases had significantly higher graft survival (100%) compared with osteochondral revisions (58.6%, <i>p</i> = 0.049). Satisfaction with revision OCAT was high (75.0%), and 84.1% would undergo the procedure again. With evidence-based patient selection, individuals who have failed previous cartilage defect surgical treatments and meet the indication criteria are likely to benefit from revision OCAT with HCV allografts. Optimal candidates for revision OCAT in the knee are patients with a history of marrow stimulation or cell-based matrix procedures who have limited comorbidities, do not require tibiofemoral bipolar OCAT, and strictly adhere to postoperative restriction and rehabilitation protocols.

Authors

Institutions

Publication Details

Journal
The Journal of Knee Surgery
Published
2025-09-29
DOI
https://doi.org/10.1055/a-2710-6069
Primary Topic
Osteoarthritis Treatment and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High-Chondrocyte-Viability Osteochondral Allograft Transplantation in the Knee for Revision of Failed Cartilage Repair Procedures

Kylee Rucinski, Steven F. DeFroda, Clayton William Nuelle, James P. Stannard et al.
The Journal of Knee Surgery
Osteoarthritis Treatment and Mechanisms
article

High-Chondrocyte-Viability Osteochondral Allograft Transplantation in the Knee for Revision of Failed Cartilage Repair Procedures

Kylee Rucinski, Steven F. DeFroda, Clayton William Nuelle, James P. Stannard, James L. Cook, JohnWilliam Moore
article en

Abstract

Revision osteochondral allograft transplantation (OCAT) has historically yielded inferior outcomes compared with primary procedures. This study evaluates outcomes following revision OCAT using high-chondrocyte-viability (HCV) OCAs for functional graft survival. A prospective registry was analyzed for HCV OCAT outcomes. Patients were grouped into primary (<i>n</i> = 182) or revision (<i>n</i> = 70) OCAT cohorts. Demographic, surgical, and follow-up data were collected. Revision cases were further subclassified based on prior cartilage procedures (marrow stimulation, osteochondral, or cell-matrix-based). Functional graft survival and validated patient-reported outcomes were assessed at a mean follow-up of 43 months. At final follow-up (FFU), functional graft survival was 79.1% for primary and 71.4% for revision OCAT. Overall survival at > 2-year follow-up was 84% (primary) and 80% (revision). Patients with failed revision OCAT reported significantly lower Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function scores at 1-year (mean: 40.8, <i>p</i> = 0.026). Bipolar tibiofemoral revisions conferred increased failure rates (odds ratio: 3.86, <i>p</i> = 0.033). Cell-matrix-based revision cases had significantly higher graft survival (100%) compared with osteochondral revisions (58.6%, <i>p</i> = 0.049). Satisfaction with revision OCAT was high (75.0%), and 84.1% would undergo the procedure again. With evidence-based patient selection, individuals who have failed previous cartilage defect surgical treatments and meet the indication criteria are likely to benefit from revision OCAT with HCV allografts. Optimal candidates for revision OCAT in the knee are patients with a history of marrow stimulation or cell-based matrix procedures who have limited comorbidities, do not require tibiofemoral bipolar OCAT, and strictly adhere to postoperative restriction and rehabilitation protocols.

The Journal of Knee SurgeryVol. 39(04)
Midwestern University (US), California Institute for Regenerative Medicine (US), Columbia Orthopaedic Group (US), University of Missouri (US)
Openalex Percentile: Top 60%
Osteoarthritis Treatment and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.